New Generic Approval: Methimazole Coated Tablets (ANADA 200-814) Important Update for ACVP Members and Veterinary Pharmacy Professionals The FDA has approved Methimazole Coated Tablets under ANADA 200-814, a generic equivalent to the pioneer product Felimazole® (NADA 141-292), for the treatment of hyperthyroidism in cats. This approval offers veterinary pharmacy professionals a reliable, cost-effective [...]
Recent Veterinary Drug Approval Updates: What Pharmacists Should Know For ACVP Members and Veterinary Pharmacy Professionals Two recent FDA actions bring noteworthy changes to veterinary pharmacotherapy—particularly for pharmacists involved in compounding and those managing inventory of critical-use medications in clinical settings. ________________________________________ Felicyn-CA1 (sirolimus) – Conditional Approval for Management of Ventricular Hypertrophy in Cats [...]
Labeling Update Alert: Librela® (bedinvetmab injection), NADA 141-562 Overview Librela® (bedinvetmab injection), the first monoclonal antibody approved in the U.S. to control osteoarthritis pain in dogs, received important label updates on February 18, 2025, under NADA 141-562. These changes reflect data gathered from real-world post-approval use since its U.S. launch in October 2023. [...]
Unapproved Pet Medications Are No Bargain—Here’s Why Your pet’s health and well-being are paramount, and when it comes to managing serious conditions like idiopathic epilepsy and seizures, the stakes couldn’t be higher. Recently, the FDA issued warnings to six online sellers of unapproved drugs that claim to treat or control seizures in dogs [...]
Top-three recognition for 14th straight year shows importance of pursuing a pro-pharmacy, pro-patient policy agenda, NACDS says 12.21.2016 "The takeaway for policymakers is that the pharmacist-patient relationship has tremendous potential to do even more to improve patient health and well-being, along with the overall quality and affordability of healthcare." click here to read the story